Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Ligand Pharmaceuticals (LGND) Return on Assets (2016 - 2025)

Historic Return on Assets for Ligand Pharmaceuticals (LGND) over the last 13 years, with Q3 2025 value amounting to 0.04%.

  • Ligand Pharmaceuticals' Return on Assets changed N/A to 0.04% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.04%, marking a year-over-year change of. This contributed to the annual value of 0.0% for FY2024, which is 0.0% changed from last year.
  • As of Q3 2025, Ligand Pharmaceuticals' Return on Assets stood at 0.04%.
  • Over the past 5 years, Ligand Pharmaceuticals' Return on Assets peaked at 0.04% during Q3 2025, and registered a low of 0.08% during Q1 2025.
  • For the 5-year period, Ligand Pharmaceuticals' Return on Assets averaged around 0.02%, with its median value being 0.02% (2021).
  • In the last 5 years, Ligand Pharmaceuticals' Return on Assets soared by 700bps in 2021 and then tumbled by -400bps in 2022.
  • Over the past 5 years, Ligand Pharmaceuticals' Return on Assets (Quarter) stood at 0.01% in 2021, then tumbled by -108bps to 0.03% in 2022, then skyrocketed by 93bps to 0.0% in 2023, then tumbled by -1432bps to 0.03% in 2024, then surged by 222bps to 0.04% in 2025.
  • Its last three reported values are 0.04% in Q3 2025, 0.07% for Q2 2025, and 0.08% during Q1 2025.